Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Hälsovård |
| Industri | Bioteknik |
The Board of Directors of Arctic Bioscience AS has resolved to extend the share option agreements for the following members of the management group: Yuming Feng (EVP Global Business Development), Daniele Mancinelli (CTO), Hogne Hallaråker (CSO) and Per Christian Sæbø (COO).
The exercise prices in the agreement for Feng is maintained at NOK 27,90 per share and maintained at NOK 9,845 per share in the agreements for Mancinelli, Hallaråker and Sæbø. The duration of the option agreements is extended until 28. February 2025.
All options being exercised into shares during the duration period will be subject to a "lock-in" period of 12 months from the time of exercise, where the shares cannot be sold or transferred without the consent of the Board.
After this, Yuming Feng holds 100 000 share options via Global Nutrios Consulting LLC, Daniele Mancinelli holds 51 570 share options, Hogne Hallaråker holds 33 030 share options and Per Christian Sæbø holds 57 390 share options.
Notifications of transactions by persons discharging managerial responsibilities are attached hereto.
This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 number 3 and the Norwegian Securities Trading Act § 5-12.